The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
I may be a little naive but my understanding of the stock market is that it is pretty much supply and demand driven with the MM, s trying to find a balance between the two. The last 2 weeks have seen buys outstripping sells almost daily. I struggle to understand why this wouldn't push the price up. In addition we supposedly have a very small free float however it seems at the moment the MMs have a never ending supply. Buys outweigh sells so much that surely they have to be running on fumes by now.
Theyknow, it would be nice. I, m hoping they, ve driven it down about as far as they can. We must be due a couple of blue days.
Nasdaq close equivalent to £1.74.
Nasdaq seems to be rallying well. Only down 1%, hopefully we are about to turn the corner.
So 2 to 3 months before the new company is up and running. The vote/record date will still need putting to bed quite soon in my opinion. I, m expect Stem newsupdate imminently.
If it floats at a value of 200 million dollars and there are around 200 million shares that equates to approx a dollar a share. At current exchange rate that equates to about 80p. Market forces will give the company its initial valuation which may well be somewhat above this, I don't see it being less and I only see the price rising as it gets established.
If Accustem floats with an estimated value of 200 million dollars. The first day of trading share price would be approx 80p. I would envisage this to rise as the company acquires market share.
My understanding is that the 57 million dollars have been bought by investor(s). There are no shares to be drip fed into the market and no sudden deluge. Like everyone else these investors will make there own decisions on how long to hang on to them or when to sell some. The investor(s) are clearly confident in Tizianas future to invest so heavily.
I think most long term holders are pretty much loaded up by now and comfortable with their positions Perhaps some still taking the opportunity to top up cheaply. Everyone just waiting on StemprintER news to drop. Once it arrives these sort of prices will just be a memory. Gla
Buys greatly outweigh sells. Pressure building to move up.
Shiraz, Good Post, totally agree. Nothing goes up in a straight line but patience will be rewarded. This is heading for the moon.
Busymumof3, There seem to be many have arrived here who have done little research into the company. Tiziana is now right in the limelight and the herd are arriving, seemingly more interested in very short term gains. Like you I am here for the long term and i have acquired a sizeable holding over the past few months and am pretty much all in for now. I believe the products TIZIANA have could be transformational in time and reap huge reward to investors. Just a little patience required. Enjoy your day.
Busymumof3. I suspect many. The herd have arrived and the bulletin board has been taken over by shorters and daytraders. Its all gone a bit mad on here.
To clarify, today's RNS refers to our drug TLZS 501to begin trials for Covid treatment in Q1 2021. Our drug Foralumub is already in trials/development so at a more advanced stage. They are announcing a second bite of the cherry folks.
To clarify the RNS refers to trials of our drug TZLS 501 which are to to commence on Q1 2021. This will be our second drug aimed at targeting Covid 19.. Not to be confused with foralumub which is already at a far more advanced stage of development. Proactive investors recently interviewed Dr Howard Weiner, one of the world's top scientists and described being " Very excited" by the results of Foralumub in early trials. TLZS 501 is Tiziana deciding to target a second of their drugs at Covid 19 people. GLA
I see this as cgreat news for the company and shareholders. A short sharp pain for long term gain. We need money to progress as quickly as possible. Now we have it. With the MM, s playing the usual games, dropping the price to spook people into selling they have also given people a great opportunity to buy/accumulate cheaply. Gla
Heat RNS. Bottom line is people, we need money to progress all our products ASAP. Now we have it. Relax, sit back and let Tiziana crack on.
Great RNS. It gives the company the money they need to move forward in the development of our products at speed. To develop and bring products to market costs money. Now we have it. Full steam ahead!!!!
City Trader. Totally agree, Just sit back, relax and make money. Tiziana will be many multiples of where we are now over the coming 12 months and all we have to do is keep away from the sell button. We, re only just setting off on the journey and I'm enjoying the ride already. Has the best prospects of any share around. Gla
I, ve just watched the Proactive Investors interview with Dr Howard Weiner from Tiziana who talks about Formaulub and its potential to treat Covid. WOW. He is one of the world's top scientists and he's ' Very Excited' by the results so far. He really thinks there on to something. If it turns out he's right I can't even imagine the worth to the company. Never known a share like this before. Potential is off the scale.